Henghao Technology Co. Limited

National Taiwan University

Chi-An Chen

Wen-Fang Cheng

Ming-Chuan Chih

A touch display includes a display module and a touch module. The touch module includes a first three-layer electrode structure and a transparent cover substrate, wherein the first three-layer electrode structure is disposed above a polarizer, and the transparent cover substrate is disposed above the first three-layer electrode structure. The first three-layer electrode structure includes a bottom index matching layer, a mesh electrode layer and a top index matching layer, wherein the mesh electrode layer is sandwiched between the bottom index matching layer and the top index matching layer.

Touch display

A touch panel includes dummy electrodes, disposed in a transmit electrode layer or a receive electrode layer whichever is below an isolation layer. In one embodiment, an anti-reflective layer includes at least one composite refractive-index three-layer structure. In another embodiment, the receive electrode layer is disposed below the isolation layer, and the receive electrode layer and the dummy electrodes are electrically coupled to a same electric potential.

Touch panel

A touch panel includes a first electrode layer and a second electrode layer disposed above a transparent substrate. At least one transparent insulating layer is disposed between the first electrode layer and the second electrode layer. The electrode pattern of the first electrode layer has more than four sides, and the electrode pattern of the second electrode layer substantially complements the electrode pattern of the first electrode layer. A gap between the first electrodes and the second electrodes is between 30 and 300 micrometers. A cover layer is formed above the second electrode layer, and magnetic force lines, generated from the first electrode and the second electrode, exist in the cover layer or pass through the cover layer.

The present invention provides a DNA vaccine, which comprises a DNA construct comprising an expression vector which is expressible in a eukaryotic cell, and a nucleotide fragment which comprises an IL-6-encoding sequence and an HPV E7-encoding sequence. In addition, the present invention also provides a pharmaceutical composition and a method of generating said DNA vaccine.

Growing community of inventors

Taipei, Taiwan

Chi-An Chen